Anna Eremieva, MD
Family Medicine · Bentonville, ARNPI 1750316634
Payments from drug & device makers
Across 191 payments — averaging $15.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$742
- Pfizer$416
- Amgen$251
- Novo Nordisk$216
- AstraZeneca$205
- Lilly USA, LLC$133
- plus $964 from 18 others
What the payments were for
- Food & beverage$2,928100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $742 |
| Pfizer | 35 | $416 |
| Amgen | 16 | $251 |
| Novo Nordisk | 13 | $216 |
| AstraZeneca | 8 | $205 |
| Lilly USA, LLC | 9 | $133 |
| Mylan Specialty L.p. | 6 | $101 |
| Boehringer Ingelheim | 4 | $98 |
| GSK | 6 | $97 |
| Sumitomo Pharma America, Inc. | 5 | $87 |
| Johnson & Johnson | 5 | $86 |
| Bayer | 4 | $79 |
| Astellas Pharma US Inc | 4 | $78 |
| Exact Sciences | 4 | $59 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Lundbeck LLC | 1 | $25 |
| Abbott | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Dynavax Technologies Corporation | 2 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
How this compares
$2,928 in reported general payments places this provider in the 75th percentile of 1,347 family medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 89 | $94,680 |
| TrulicityDulaglutide | 47 | $70,477 |
| XareltoRivaroxaban | 65 | $68,444 |
| MounjaroTirzepatide | 46 | $48,850 |
| EliquisApixaban | 32 | $46,867 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 47 | $41,186 |
| JardianceEmpagliflozin | 39 | $33,080 |
| Tresiba Flextouch U-200Insulin Degludec | 38 | $31,141 |
| Emgality PenGalcanezumab-Gnlm | 32 | $25,270 |
| WegovySemaglutide | 17 | $22,758 |
| LinzessLinaclotide | 26 | $21,152 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $15,185 |
| MovantikNaloxegol Oxalate | 22 | $12,088 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $11,027 |
| Repatha SureclickEvolocumab | 11 | $10,828 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $133 | $119,32793 claims |
| Novo NordiskOzempic, Wegovy | $216 | $117,439106 claims |
| Johnson & JohnsonXarelto | $86 | $68,44465 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $97 | $61,40080 claims |
| PfizerEliquis | $416 | $46,86732 claims |
| Boehringer IngelheimJardiance | $98 | $33,08039 claims |
| AbbVieLinzess | $742 | $21,15226 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $205 | $17,06136 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Bentonville
- Scott MusickBentonville$102K
- Craig LevoyBentonville$30K
- Rossitza HristoskovaBentonville$14K
- Graeme ArcherBentonville$13K
- George KonisLittle Rock$26.6M
- Kevin RobertsLittle Rock$2.5M
- Derek LewisLittle Rock$1.7M
- Jodi SansonHot Springs$1.7M
- Senthil RaghavanLittle Rock$496K
- Broderick EatonWynne$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.